Search Results
Results found for "preclinical pharmacology"
- Unlocking Cell's Secrets: Spontaneous β-Arrestin-Membrane Preassociation Drives Receptor-Activation
Pharmacol. Toxicol. 52, 179–197. https://doi.org/10. 1146/annurev.pharmtox.010909.105800 Tsao, P. Pharmacology & therapeutics, 89(2), 139–147. https://doi.org/10.1016/s0163-7258(00)00107-8
- 📰 GPCR Weekly News, August 28 to September 3, 2023
female common diseases: a guard of women's health β-Arrestins: Structure, Function, Physiology, and Pharmacological Postdoc Research Associate Director, Regulatory Affairs Research Scientist/Senior Scientist I - Molecular Pharmacology
- GPCR Drug Discovery Summit 2026: What to Expect in Boston — and How to Register
discovery through translation — experts in GPCR biology, structural biology, computational design, pharmacology
- 📰 GPCR Weekly News, March 20 to 26, 2023
(June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023). Adrenoceptors and GPCR Signalling (June 30 - July 1, 2023) 19th World Congress of Basic & Clinical Pharmacology IRN I-GPCRNet (October 25 - 27, 2023) GPCR Jobs NEW Team Lead protein production and profiling NEW Pharmacologist
- Coincident Regulation of PLCβ Signaling by Gq-Coupled and μOpioid Receptors Opposes Opioid- Mediated
Knockout of PLCβ3, or pharmacological inhibition of its upstream regulators, Gβγ or Gq, ex vivo in periaqueductal
- 📰 GPCR Weekly News, November 13 to 19, 2023
for substrate linear polyubiquitination GPCR Binders, Drugs, and more Dual allosteric and orthosteric pharmacology 2024 | 9th GPCRs in Medicinal Chemistry July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology
- A broad look into the future of systemic sclerosis
Pharmacological interventions, although for other indications, are already in clinical use to address
- Pepducin-mediated G Protein-Coupled Receptor Signaling in the Cardiovascular System
Over the past 2 decades, pepducins have progressed initially from pharmacologic tools used to manipulate
- GPCR kinase phosphorylation of distal C-tail sites specifies βarrestin1-mediated signaling by...
We demonstrate by pharmacologic inhibition of GRK2/3-mediated phosphorylation of the chemokine receptor
- GB83, an Agonist of PAR2 with a Unique Mechanism of Action Distinct from Trypsin and PAR2-AP
bona fide agonist of PAR2 that uniquely modulates PAR2-mediated cellular signaling and is a useful pharmacological
- Using Live-cell High-Content Screening to Characterize CB2 Ligands: Insights From 16 Synthetic Cannabinoids
Despite its therapeutic potential, CB2 pharmacology remains difficult to interrogate with confidence. membrane mixtures, altered receptor conformations, and non-specific interactions introduce noise at precisely Early triage becomes more precise. For researchers working in cannabinoid pharmacology, inflammation, or GPCR-mediated analgesia, these cellular context will be increasingly important for designing ligands with both potency and functional precision
- Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...
The development of new CB2-related pharmacological and genetic tools, including the first small molecule
- Dr. Kevin Pfleger and Dr. Elizabeth Johnstone were awarded one of the 2022 Diabetes Research...
This $60,000 grant from Diabetes Research WA will assist the Perkins' Molecular Endocrinology and Pharmacology
- Therapeutic validation of an orphan G protein‐coupled receptor
In this study Marsango et al. address two key questions in GPR84 biology and pharmacology: 1. how GPR84 ligands (Pillaiyar et al., 2018) with biased properties which can help to better elucidate the molecular pharmacology
- Rhodopsin as a Molecular Target to Mitigate Retinitis Pigmentosa
chaperones to improve the folding and stability of the mutant receptor is one of the most promising pharmacological
- 📰 GPCR Weekly News, December 11 to 17, 2023
The course covers basic pharmacology in four weekly segments. Only 14 out of 20 spots remain. , 2024 | 11th Adhesion GPCR Workshop July 12 - 17, 2026 | 20th World Congress of Basic and Clinical Pharmacology
- Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR...
Finally, we validated A2BAR as a potential pharmacological tool in CRC, using selective antagonists,
- In vitro assays for the functional characterization of (psychedelic) substances at the serotonin...
perception, and thought, and have the activation of serotonin (5-HT) 2A receptors (5-HT2A Rs) as a main pharmacological
- Delineation of GPR15 receptor-mediated Gα protein signaling profile in recombinant mammalian cell
Here, GPR15L(25-81) and GPR15L(71-81) are used as pharmacological tool compounds to delineate the GPR15
- Adrenal G Protein-Coupled Receptors and the Failing Heart: A Long-distance, Yet Intimate Affair
Despite considerable advances in pharmacological treatment, HF represents a severe clinical and social
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
Kenakin’s latest lecture delivers a paradigm shift for pharmacologists working on drugs where in vitro future topics Access to the study group Whether you’re in hit-to-lead, lead optimization, or clinical pharmacology
- Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify...
The pharmacological profiles and mechanistic insights of our study provide clues for the future design
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
In the realm of molecular research, precise interpretation is crucial; a misread curve can lead to lost Terry's Corner - The Truth About Allosteric Displacement Allosteric binding isn’t just a twist in the pharmacology Eliminate chaos tax: Every two-week delay in DMTA cycles costs hundreds of thousands—avoidable with precision GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need
- New role of β-arrestins in MOR signaling
non-medically for euphoric feelings and medically for pain relief, although the last one comes with pharmacological pathophysiological significance in pain, addiction and depression opioid receptors represent important pharmacological
- TLR4 biased small molecule modulators
Biased pharmacological modulators provide potential therapeutic benefits, including greater pharmacodynamic
- 📰 GPCR Weekly News, March 27 to April 4, 2023
on structure-function studies for membrane proteins in collaboration with AstraZeneca Expansion of precision (June 4 - 8, 2023). 2023 Molecular Pharmacology (GRS) Seminar GRC. (June 10 - 11, 2023). Adrenoceptors and GPCR Signalling (June 30 - July 1, 2023) 19th World Congress of Basic & Clinical Pharmacology Research NEW PostDoctoral Associate NEW PostDoctoral Position Team Lead protein production and profiling Pharmacologist
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
agricultural settings inspired him to train in veterinary medicine, where he was introduced to physiology and pharmacology Emerging direction: Peptide–drug conjugates for precision targeting.
- Innovative Data-Driven Solutions: The pHSense Revolution
This innovation emerged from years of foundational work in photophysics and GPCR pharmacology.
- Coordinated transcriptomics and peptidomics of central nervous system identify neuropeptides and ...
together, these results will benefit further investigations to determine physiological functions and pharmacological
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
Flow Cytometry validation performed in the Oncological Pharmacology Laboratory of the University of Turin








